MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$189,516K
EPS
-$0.24
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
-147,292 131,096 208,021
Reclassification of unrealized loss on short-term investments to other expense, net
0 0* 0 0
Acquired in-process research and development
-0 0 0
Interest expense
0 0 0 0
General and administrative
62,594 77,633 103,115 360,416
Total operating expenses
195,212 224,925 234,211 568,437
Other income, net
5,788 5,753 2,418 2,729
Net loss
-189,424 -219,172 -231,793 -565,708
Reclassification of cumulative currency translation gain to other income, net
-0* --
Foreign currency translation adjustments
84 -36 43 -189
Unrealized gain (loss) on short-term investments
-176 205 0 0
Comprehensive loss
-189,516 -219,003 -231,750 -565,897
Basic EPS
-0.24 -0.286 -0.31 -0.76
Diluted EPS
-0.24 -0.286 -0.31 -0.76
Basic Average Shares
775,458,141 766,702,133 743,415,917 742,615,007
Diluted Average Shares
775,458,141 766,702,133 743,415,917 742,615,007
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$189,516K (-199.91%↓ Y/Y)Foreign currencytranslation adjustments$84K (157.93%↑ Y/Y)Net loss-$189,424K (-201.09%↓ Y/Y)Unrealized gain (loss) onshort-term investments-$176K (-32.33%↓ Y/Y)Other income, net$5,788K (46.98%↑ Y/Y)Total operatingexpenses$195,212K (192.01%↑ Y/Y)something is missing$132,618K General andadministrative$62,594K (301.60%↑ Y/Y)

summitplc-logo_05fd32df-svg

Summit Therapeutics Inc. (SMMT)

summitplc-logo_05fd32df-svg

Summit Therapeutics Inc. (SMMT)